GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MariMed Inc (XCNQ:MRMD) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

MariMed (XCNQ:MRMD) Total Revenue Growth Rate (Future 3Y To 5Y Est) : 18.66 (As of Jun. 04, 2024)


View and export this data going back to 2022. Start your Free Trial

What is MariMed Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est) is 18.66.


Competitive Comparison of MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Drug Manufacturers - Specialty & Generic subindustry, MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



MariMed  (XCNQ:MRMD) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


MariMed Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of MariMed's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


MariMed (XCNQ:MRMD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MariMed Inc (XCNQ:MRMD) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)
Traded in Other Exchanges
Address
10 Oceana Way, Floor 2, Norwood, MA, USA, 02062
MariMed Inc is a multi-state operator in the United States cannabis industry. It develops, operates, manages, and optimizes regulatory-compliant facilities for the cultivation, production, and dispensing of medical and adult-use cannabis. MariMed also licenses its proprietary brands of cannabis products along with other top brands in domestic markets Sources of revenue are comprised of Product sales (retail and wholesale), Real estate rental income, Supply procurement, Management fees, and Licensing fees.
Executives
Jon R. Levine Senior Officer
Timothy Shaw Senior Officer

MariMed (XCNQ:MRMD) Headlines

From GuruFocus

MariMed Supports Giving At Thanksgiving

By Value_Insider Value_Insider 11-16-2022

MariMed Closes $35 Million Credit Facility to Accelerate its Strategic Growth Plans

By Stock market mentor Stock market mentor 01-24-2023

MariMed Announces Thrive Wellness Dispensary Opening Tiffin, Ohio

By sperokesalga sperokesalga 06-12-2023

MariMed Reports Second Quarter 2023 Earnings

By Marketwired 08-02-2023

MariMed Announces Fourth Quarter 2022 Earnings Date

By Stock market mentor Stock market mentor 02-01-2023

MariMed Strengthens Sales, Marketing, and R&D Teams With Senior Executive Hires

By Stock market mentor Stock market mentor 01-17-2023